Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer

被引:8
|
作者
Abbas, Ghulam [1 ]
Danish, Adnan [2 ]
Krasna, Mark J. [3 ]
机构
[1] Meridian Hlth, Minimally Invas Thorac Surg, 1 Riverview Plaza, Red Bank, NJ 07701 USA
[2] Meridian Hlth, Radiat Oncol, 1 Riverview Plaza, Red Bank, NJ 07701 USA
[3] Jersey Shore Univ, Meridian Canc Care, Med Ctr, Ackerman South, Room 553,1945 Route 33, Neptune, NJ 07753 USA
关键词
Stereotactic body radiation therapy (SBRT); Radiofrequency ablation; Microwave ablation; Ablative therapies for lung cancer; Stereotactic ablative therapy (SABR); PERCUTANEOUS RADIOFREQUENCY ABLATION; MEDICALLY INOPERABLE PATIENTS; HIGH-RISK PATIENTS; PHASE-II TRIAL; STAGE-I; RADIATION-THERAPY; SUBLOBAR RESECTION; ANATOMIC SEGMENTECTOMY; MATCHED ANALYSIS; DOSE-ESCALATION;
D O I
10.1016/j.soc.2016.02.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard and have the potential to be the standard for operable patients with early stage lung cancer who are high risk due to co- morbidities. The most commonly used ablative modalities include stereotactic body radiation therapy, microwave ablation, and radiofrequency ablation.
引用
收藏
页码:553 / +
页数:15
相关论文
共 50 条
  • [21] Clinical stereotactic ablative body radiotherapy on patients with early-stage inoperable lung cancer
    Yeo, R.
    Nariyangadu, P.
    Shah, N.
    Tsang, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S376 - S376
  • [22] Surgery and stereotactic ablative body radiotherapy for colorectal cancer lung oligometastases: One centre experience
    Piedra-Cascon, A.
    Virgili Manrique, A. C.
    Martinez Tellez, E.
    Farre Bernado, N.
    Trujillo, J. C.
    Balart Serra, J.
    Sebio Garcia, A.
    Szafranska, J.
    Aguado Sorolla, M.
    Gallardo Melo, P.
    Paez, D.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S541 - S541
  • [23] Experience of stereotactic ablative body radiotherapy for radically treatable lung cancer in a District General Hospital
    Ni Griannna, O.
    Mc Cormick, H.
    Kelly, M. G.
    King, C.
    Sharkey, R.
    Mc Closkey, M.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S27 - S28
  • [24] Editorial: Stereotactic body radiotherapy for lung cancer
    Liu, An
    Kroeze, Stephanie G. C.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] Stereotactic body radiotherapy in lung cancer: an update
    Cintra Vita Abreu, Carlos Eduardo
    Rodrigues Ferreira, Paula Pratti
    de Moraes, Fabio Ynoe
    Pimenta Neves, Wellington Furtado, Jr.
    Gadia, Rafael
    Carvalho, Heloisa de Andrade
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2015, 41 (04) : 376 - 387
  • [26] Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
    Correa, Rohann J. M.
    Palma, David A.
    [J]. LANCET ONCOLOGY, 2021, 22 (01): : 6 - 8
  • [27] Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)
    Devpura, S.
    Siddiqui, M. S.
    Chen, D.
    Liu, D.
    Li, H.
    Kumar, S.
    Gordon, J.
    Ajlouni, M.
    Movsas, B.
    Chetty, I. J.
    [J]. XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013), 2014, 489
  • [28] All-cause hospital admissions after stereotactic ablative body radiotherapy for primary lung cancer
    Ariyaratne, Hemal
    Wong, Swee-Ling
    Docherty, Catherine
    [J]. CLINICAL ONCOLOGY, 2022, 34 : E17 - E17
  • [29] An investigation into the efficacy and toxicity of stereotactic ablative body radiotherapy for lung cancer at The Christie NHS Foundation Trust
    Elsesser, S.
    Bayman, N.
    McCloskey, P.
    Davidson, L.
    Dearden, R.
    Whitehurst, P.
    Burt, P. A.
    Chittalia, A.
    Coote, J.
    Harris, M.
    Lee, L.
    Pemberton, L.
    Sheikh, H.
    Faivre-Finn, C.
    [J]. LUNG CANCER, 2014, 83 : S60 - S61
  • [30] Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
    Ghandourh, Wsam
    Holloway, Lois
    Batumalai, Vikneswary
    Chlap, Phillip
    Field, Matthew
    Jacob, Susannah
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 34 : 7 - 14